ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Vicente C. DeGuzman
Mark S. Soberman
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mortman, K. D.
Right arrow Articles by Soberman, M. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mortman, K. D.
Right arrow Articles by Soberman, M. S.

Ann Thorac Surg 1997;64:1434-1436
© 1997 The Society of Thoracic Surgeons

Original Articles: General Thoracic

Pulmonary Metastases in Pseudomyxoma Peritonei Syndrome

Keith D. Mortman, MD, Paul A. Sugarbaker, MD, Barry M. Shmookler, MD, Vicente C. DeGuzman, MD, Mark S. Soberman, MD

Section of Thoracic Surgery, Department of Surgery; Department of Pathology; and Sections of Thoracic Oncology and Surgical Oncology, Washington Cancer Institute, Washington Hospital Center, Washington, DC

Accepted for publication May 2, 1997.

Background. Pseudomyxoma peritonei (PMP) is a rare disease arising from a mucinous cystadenoma of appendiceal origin. The syndrome has been characterized by progressive growth of mucinous tumors, tense mucinous ascites, and ultimately death. Abdominal and pelvic recurrence after resection of intraperitoneal disease occurs in all patients unless adjunctive measures are taken. Local spread of PMP by direct extension to the pleural or pericardial space is uncommon but has been reported in the literature. Here we report development of pulmonary parenchymal metastases after treatment for PMP.

Methods. The charts of 3 patients were retrospectively reviewed for the presentation and management of metastatic PMP.

Results. Three patients underwent resection for pulmonary parenchymal metastases of PMP. All patients recovered uneventfully. They continue to do well after 2 to 8 years of follow-up.

Conclusions. Pulmonary metastasectomy for PMP is safe and effective after treatment of intraperitoneal disease.




This article has been cited by other articles:


Home page
 Ann. Thorac. Surg.Home page
A. A. Khan, J. Tambiah, P. Cane, and L. Lang-Lazdunski
Prolonged Survival in a Patient With Recurrent Pulmonary Metastases Secondary to Mucinous Cystadenocarcinoma of the Appendix With Pseudomyxomatous Peritonei
Ann. Thorac. Surg., May 1, 2007; 83(5): 1893 - 1894.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1997 by The Society of Thoracic Surgeons.